Anixa Biosciences, Inc. (ANIX)
3.625
-0.08
(-2.29%)
USD |
NASDAQ |
Aug 24, 16:00
3.62
0.00 (0.00%)
After-Hours: 20:00
Anixa Biosciences Total Assets (Quarterly) : 14.86M for April 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | 14.86M |
| January 31, 2026 | 15.23M |
| October 31, 2025 | 16.08M |
| July 31, 2025 | 17.65M |
| April 30, 2025 | 16.98M |
| January 31, 2025 | 18.91M |
| October 31, 2024 | 21.59M |
| July 31, 2024 | 22.91M |
| April 30, 2024 | 24.36M |
| January 31, 2024 | 25.37M |
| October 31, 2023 | 25.52M |
| July 31, 2023 | 26.58M |
| April 30, 2023 | 27.60M |
| January 31, 2023 | 28.31M |
| October 31, 2022 | 30.41M |
| July 31, 2022 | 32.56M |
| April 30, 2022 | 32.80M |
| January 31, 2022 | 35.24M |
| October 31, 2021 | 36.26M |
| July 31, 2021 | 37.06M |
| April 30, 2021 | 38.50M |
| January 31, 2021 | 14.60M |
| October 31, 2020 | 9.453M |
| July 31, 2020 | 9.362M |
| April 30, 2020 | 5.925M |
| Date | Value |
|---|---|
| January 31, 2020 | 6.164M |
| October 31, 2019 | 6.294M |
| July 31, 2019 | 6.843M |
| April 30, 2019 | 7.765M |
| January 31, 2019 | 6.470M |
| October 31, 2018 | 6.448M |
| July 31, 2018 | 7.294M |
| April 30, 2018 | 7.361M |
| January 31, 2018 | 7.491M |
| October 31, 2017 | 8.812M |
| July 31, 2017 | 8.415M |
| April 30, 2017 | 7.250M |
| January 31, 2017 | 4.218M |
| October 31, 2016 | 5.628M |
| July 31, 2016 | 6.321M |
| April 30, 2016 | 7.206M |
| January 31, 2016 | 8.647M |
| October 31, 2015 | 9.336M |
| July 31, 2015 | 10.28M |
| April 30, 2015 | 11.13M |
| January 31, 2015 | 13.27M |
| October 31, 2014 | 9.055M |
| July 31, 2014 | 18.40M |
| April 30, 2014 | 15.50M |
| January 31, 2014 | 15.33M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Vicapsys Life Sciences, Inc. | 0.1325M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.641M |
| Shareholders Equity (Quarterly) | 14.48M |
| Debt to Equity Ratio | 0.0127 |
| Current Ratio | 9.788 |
| Net Debt Paydown Yield | 0.01% |